David Hollander - CMO & Global Therapeutics Lead at Revance Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CMO & Global Therapeutics Lead
Stock Symbol
RVNC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Hollander since 7/7/2023

Holdings reported by David Hollander for Revance Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 108,853 $813 K $7.47 Feb 27, 2024 Direct

There are no transactions reported by David Hollander for Revance Therapeutics, Inc.